Streetbeat News

Stock Prices

PBR

Petrobras shares are trading higher following an agreement between Brazilian ministers for the company to pay extraordinary dividends. This development is seen as a positive move for shareholders, potentially increasing the stock's attractiveness.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:02 pm

VVOS

Vivos Therapeutics' shares surged following the announcement of a notice of allowance for its U.S. patent application for a device aimed at treating sleep disordered breathing, sleep apnea, and snoring.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:01 pm

BV

Brightview Holdings Inc (NYSE:BV) shares fell after a recent surge, due to a downgrade by Goldman Sachs from Neutral to Sell, despite a price target increase from $8 to $10. The downgrade is based on the company's strategy to exit low-margin contracts, which is expected to negatively impact revenues, especially in its landscape maintenance business. Additionally, a warmer 2023-2024 winter is anticipated to reduce snow removal revenue, further challenging the company's financial outlook.

Portfolio Pulse from Priya Nigam

April 04, 2024 | 4:00 pm

BFH

Bread Finl Hldgs (NYSE:BFH) has been analyzed by 7 analysts, showing a shift towards a more positive outlook with an average 12-month price target of $38.29, up 18.43% from the previous $32.33. Analyst actions range from 'Outperform' to 'Underweight', reflecting diverse perspectives on the company's performance. Bread Financial, known for its credit card and loyalty program services, faces challenges in revenue growth and efficiency metrics but maintains a strong net margin.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 4:00 pm

F

TSLA

Tesla shares are trading higher, potentially due to Ford's delay in its all-electric SUV production. Additionally, Tesla is considering importing cars made at Giga-Berlin to India.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:00 pm

STAA

Staar Surgical (NASDAQ:STAA) has been evaluated by 4 analysts over the last three months, showing a mix of bullish and indifferent sentiments. The average 12-month price target is $44.5, reflecting a 4.71% increase from the previous $42.50. Analyst actions include maintaining, raising, and lowering ratings and price targets. Staar Surgical, a manufacturer of implantable lenses, has shown solid revenue growth of 19.09% as of December 31, 2023, with a net margin of 10.17% and exceptional ROE and ROA, indicating strong financial health.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 4:00 pm

ACHL

ALUR

CADL

CAG

EFTR

KWE

TCBP

Nasdaq rose 1% with ConAgra Brands reporting better-than-expected Q3 earnings, leading to a positive market sentiment. Real estate and healthcare sectors saw gains, while TC Biopharm, Allurion Technologies, and Candel Therapeutics experienced significant stock increases. Conversely, eFFECTOR Therapeutics, Achilles Therapeutics, and KWESST Micro Systems saw notable declines. Oil prices slightly dropped, while gold and silver prices increased.

Portfolio Pulse from Avi Kapoor

April 04, 2024 | 3:58 pm

QQQ

SPY

The Bureau of Labor Statistics is set to release the March jobs report, with ADP's data showing strong private sector employment growth. Economists predict a surge of 200,000 non-farm payrolls, a decline from the previous month but still robust. Strong job growth in specific sectors and cooling inflation are noted. Expectations of the Federal Reserve's monetary policy could shift based on the report's outcome, affecting Treasury yields, the dollar, and interest rate-sensitive sectors. The SPDR S&P 500 ETF Trust and Invesco QQQ Trust experienced declines following the previous jobs report.

Portfolio Pulse from Piero Cingari

April 04, 2024 | 3:54 pm

DJT

Trump Media & Technology Group Corp (NASDAQ:DJT) shares are trading lower amid volatility after its Nasdaq debut. The company reported a $58.19 million net loss for 2023, with revenue of $4.13 million. The loss includes nearly $40 million in interest expense, and the company ended the year with $2.6 million in cash. Despite warnings of continued losses, the stock has surged, partly due to speculation about its role in Trump's potential re-election campaign and its popularity as a meme stock.

Portfolio Pulse from Adam Eckert

April 04, 2024 | 3:51 pm

SNPX

Synaptogenix Inc (NASDAQ:SNPX) announced a 1-for-25 reverse stock split to meet Nasdaq's minimum bid price requirement. The reverse split will reduce outstanding shares to about 1,085,333, affecting all shareholders uniformly. This move is aimed at increasing the per-share trading price, with trading on a split-adjusted basis starting on Friday.

Portfolio Pulse from Henry Khederian

April 04, 2024 | 3:49 pm